Cite

HARVARD Citation

    Crotti, C. et al. (n.d.). AB0922 BUROSUMAB (ANTI-FGF23 MONOCLONAL ANTIBODY) IN THE TREATMENT OF A PATIENT WITH RECURRENT TUMOR INDUCED OSTEOMALACIA.. Annals of the rheumatic diseases. p. 1762. [Online]. 
  
Back to record